Home > Financial Ratios > ORCHID PHARMA

ORCHID PHARMA
Fixed Capital/Sales

    Back to All Ratios
COMMUNITY POLL
for ORCHID PHARMA
Please provide your vote to see the results

ORCHID PHARMA Last 5 Year Fixed Capital/Sales History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Fixed Capital/Sales(x) 1.541.802.102.692.86

What is the latest Fixed Capital/Sales ratio of ORCHID PHARMA ?

The latest Fixed Capital/Sales ratio of ORCHID PHARMA is 1.54 based on Mar2024 Consolidated results.
Year Fixed Capital/Sales
Mar20241.54
Mar20231.80
Mar20222.10
Mar20212.69
Mar20202.86

How is Fixed Capital/Sales of ORCHID PHARMA Trending?

Years Fixed Capital/Sales % Change
Mar2024 1.54
-14.44
Mar2023 1.8
-14.29
Mar2022 2.1
-21.93
Mar2021 2.69
-5.94
Mar2020 2.86 -

Other Financial Ratios of ORCHID PHARMA


Compare Fixed Capital/Sales ratio of peers of ORCHID PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
ORCHID PHARMA ₹7,828.8 Cr -3.7% -13.8% 124.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹422,715.0 Cr 0.3% -2.6% 36.7% Stock Analytics
DIVIS LABORATORIES ₹154,460.0 Cr -1% -0.5% 60.8% Stock Analytics
CIPLA ₹115,271.0 Cr -1.4% -3.1% 11.8% Stock Analytics
DR REDDYS LABORATORIES ₹107,511.0 Cr -3.8% -4% 15.3% Stock Analytics
ZYDUS LIFESCIENCES ₹99,189.5 Cr 0.1% 1.2% 40.3% Stock Analytics


ORCHID PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
ORCHID PHARMA

-3.7%

-13.8%

124.7%

SENSEX

-0.9%

-4.3%

3.7%


You may also like the below Video Courses